Wed, May 14, 2008
Oncology Product Research
Pre-
Clinical
IND
Filing
Phase
I
Phase
II
Phase
III
FDA
Appr-oval
Phase
IV
GROWTH FACTOR BLOCKERS
Flt-3 MAb
INDICATION: AML, ALL
VEGFR-3 MAb
INDICATION: Solid tumors
VE-cadherin MAb
INDICATION: Solid tumors
FGFR MAb
INDICATION: Solid tumors
Ron MAb
INDICATION: Solid tumors
TRP-1 MAb
INDICATION: Solid tumors
PDGFRß MAb
INDICATION: Solid tumors
Neuropilin MAb
INDICATION: Solid tumors
Company Overview
|
Clinical Programs
|
Research
|
News
|
Investor Relations
|
Calendar
|
Careers
|
Product Support Program
© 2008 ImClone Systems Incorporated
